# Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions

> **NCT05209412** · NA · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 370 (actual)

## Conditions studied

- De Novo Stenosis
- Coronary Artery Disease
- Percutaneous Coronary Intervention

## Interventions

- **DEVICE:** Lepu Paclitaxel coated balloon
- **DEVICE:** Resolute Integrity Zotarolimus eluting stents
- **DRUG:** Aspirin
- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT05209412
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2024-02-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 370 (ACTUAL)
- **Last updated:** 2024-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05209412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05209412, "Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05209412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*